Clinical trials
Terminated Hyperkalemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2013 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| Ardelyx | 1 |
| Comprehensive Research Associates | 1 |
| Relypsa, Inc. | 1 |
| US Department of Veterans Affairs | 1 |
| University Hospitals Cleveland Medical Center | 1 |
| Vifor Pharma, Inc. | 1 |
| ZS Pharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperkalemia | 12 |
| Renal Insufficiency, Chronic | 3 |
| Acidosis | 1 |
| Acute Kidney Injury | 1 |
| Atrial Fibrillation | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Emergencies | 1 |
| Heart Failure | 1 |
| Kidney Diseases | 1 |
| Tachycardia, Ventricular | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.